Catalyst Pharmaceutical
CPRX
CPRX
188 hedge funds and large institutions have $459M invested in Catalyst Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 72 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 72
21% less capital invested
Capital invested by funds: $583M → $459M (-$125M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
188
Holding in Top 10
2
Calls
$715K
Puts
$141K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$5.74M | |
| 3 | +$5.66M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$5.27M |
| 5 |
Renaissance Technologies
New York
|
+$4.76M |
Top Sellers
| 1 | -$4.98M | |
| 2 | -$4.29M | |
| 3 | -$3.44M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2.39M |
| 5 |
Man Group
London,
United Kingdom
|
-$2.12M |